journal cover

Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis

Modern Rheumatology

Jul 10, 2009

Ryuji KoikeNobuyuki Miyasaka

Get paper from

Abstract

The introduction of biological agents targeting tumor necrosis factor-alpha (TNF-alpha) has brought about a paradigm shift in the treatment of rheumatoid arthritis (RA). Although these anti-TNF agents have excellent efficacy against RA, a substantial number of patients still show inadeq...read more

Mentioned in this Paper

Antirheumatic Agents
Monoclonal Antibodies
Rheumatoid Arthritis
Biological Factors
Clinical Trials
Communicable Diseases
Immune System
Interleukin-6
Rheumatology Specialty
Signs and Symptoms
Paper Details
References
  • References29
  • Citations32
123
  • References29
  • Citations32
1234

Similar Papers Found In These Feeds

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

Human Immune Variation: Genetics, Gender & Time

Establishing the normal range of phenotypic variation within and between individuals requires consideration of contributions from genetics and the environment. Find the latest research on variations in the human immune system here.

Immune System in Humans: Tissues & Ages

Mapping the human immune system spatially, within and between tissues, will provide the basis for studying mechanisms of tissue residency and the effects of aging. Find new research on analysis of the immune system by multiple approaches here.

Wound Healing

Wound healing is a complex biologic process that involves the integration of inflammation, mitosis, angiogenesis, synthesis, and remodeling of the extracellular matrix. Here is the latest research.

Human Immune Variation: Genetic, Gender & Time

Establishing the normal range of phenotypic variation within and between individuals requires consideration of contributions from genetics and the environment. Find the latest research on variations in the human immune system here.

Immunomodulating Agents

Immunomodulating agents are substances that stimulate or suppresse the immune system and may help the body combat againsts cancer, infection, or other diseases. Discover the latest research on immunomodulating agents here.

© 2019 Meta ULC. All rights reserved

Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis

Modern Rheumatology

Jul 10, 2009

Ryuji KoikeNobuyuki Miyasaka

PMID: 19590933

DOI: 10.1007/s10165-009-0197-6

Abstract

The introduction of biological agents targeting tumor necrosis factor-alpha (TNF-alpha) has brought about a paradigm shift in the treatment of rheumatoid arthritis (RA). Although these anti-TNF agents have excellent efficacy against RA, a substantial number of patients still show inadeq...read more

Mentioned in this Paper

Antirheumatic Agents
Monoclonal Antibodies
Rheumatoid Arthritis
Biological Factors
Clinical Trials

Similar Papers Found In These Feeds

Related Papers

Paper Details
References
  • References29
  • Citations32
123
  • References29
  • Citations32
1234

Get paper from

/papers/japan-college-of-rheumatology-2009-guidelines-for/19590933